58,081 Shares in Cognex Corporation $CGNX Acquired by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC purchased a new position in Cognex Corporation (NASDAQ:CGNX) in the second quarter, Holdings Channel reports. The fund purchased 58,081 shares of the scientific and technical instruments company’s stock, valued at approximately $1,842,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. raised its holdings in shares of Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after purchasing an additional 736 shares in the last quarter. Penserra Capital Management LLC acquired a new position in shares of Cognex during the second quarter worth $29,000. MassMutual Private Wealth & Trust FSB increased its holdings in Cognex by 231.9% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company’s stock valued at $34,000 after buying an additional 756 shares during the last quarter. Farther Finance Advisors LLC increased its holdings in Cognex by 31.5% in the second quarter. Farther Finance Advisors LLC now owns 1,277 shares of the scientific and technical instruments company’s stock valued at $40,000 after buying an additional 306 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd raised its stake in Cognex by 82.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,749 shares of the scientific and technical instruments company’s stock valued at $52,000 after buying an additional 791 shares in the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on CGNX shares. Barclays reaffirmed an “overweight” rating and set a $56.00 price objective (up from $55.00) on shares of Cognex in a research report on Friday, October 31st. The Goldman Sachs Group boosted their target price on Cognex from $36.00 to $40.00 and gave the stock a “sell” rating in a research note on Tuesday, September 16th. KeyCorp reaffirmed an “overweight” rating and issued a $50.00 price target on shares of Cognex in a report on Friday, October 31st. Citigroup reissued a “neutral” rating and set a $37.00 price objective (up previously from $30.00) on shares of Cognex in a report on Monday, July 14th. Finally, UBS Group restated a “buy” rating and set a $58.00 price objective on shares of Cognex in a research report on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $46.20.

Cognex Stock Down 1.8%

CGNX opened at $38.58 on Tuesday. Cognex Corporation has a 52 week low of $22.67 and a 52 week high of $49.76. The business’s 50 day moving average is $44.81 and its two-hundred day moving average is $37.81. The firm has a market cap of $6.47 billion, a price-to-earnings ratio of 60.28 and a beta of 1.52.

Cognex (NASDAQ:CGNX) last announced its earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.06. The business had revenue of $276.89 million for the quarter, compared to analyst estimates of $261.86 million. Cognex had a net margin of 11.33% and a return on equity of 8.26%. The company’s revenue for the quarter was up 18.0% compared to the same quarter last year. During the same period last year, the firm posted $0.20 earnings per share. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. Equities analysts expect that Cognex Corporation will post 0.61 EPS for the current fiscal year.

Cognex Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 28th. Shareholders of record on Thursday, November 13th will be paid a $0.085 dividend. This is a boost from Cognex’s previous quarterly dividend of $0.08. This represents a $0.34 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Thursday, November 13th. Cognex’s dividend payout ratio (DPR) is presently 53.13%.

Insider Transactions at Cognex

In other news, Director Robert Willett sold 6,704 shares of the stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total transaction of $331,915.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Sheila Marie Dipalma sold 2,000 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $45.03, for a total value of $90,060.00. Following the transaction, the executive vice president directly owned 6,582 shares in the company, valued at approximately $296,387.46. This represents a 23.30% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 10,706 shares of company stock valued at $512,065 over the last ninety days. Corporate insiders own 1.60% of the company’s stock.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.